These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1812349)

  • 1. Metal ion release from paramagnetic chelates: what is tolerable?
    Rocklage SM; Worah D; Kim SH
    Magn Reson Med; 1991 Dec; 22(2):216-21; discussion 229-32. PubMed ID: 1812349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and characterization of nonionic paramagnetic metal complexes as potential magnetic resonance imaging contrast agents.
    White DH; Rajagopalan R; Kuan KT; Lin Y; Wallace RA; Rogic MM; Bosworth ME; Robbins MS; Ralston WH; Adams MD
    Invest Radiol; 1990 Sep; 25 Suppl 1():S56-7. PubMed ID: 2126534
    [No Abstract]   [Full Text] [Related]  

  • 3. A pharmacokinetic and MRI study of unilamellar gadolinium-, manganese-, and iron-DTPA-stearate liposomes as organ-specific contrast agents.
    Schwendener RA; Wüthrich R; Duewell S; Wehrli E; von Schulthess GK
    Invest Radiol; 1990 Aug; 25(8):922-32. PubMed ID: 2394576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nephrogenic systemic fibrosis (NSF): Effects of stricter guidelines on the use of contrast media containing gadolinium].
    Hägele J; Simon M
    Radiologe; 2011 Oct; 51(10):831-2. PubMed ID: 21947240
    [No Abstract]   [Full Text] [Related]  

  • 5. [Physico-chemical and toxicological profile of gadolinium chelates as contrast agents for magnetic resonance imaging].
    Idée JM; Fretellier N; Thurnher MM; Bonnemain B; Corot C
    Ann Pharm Fr; 2015 Jul; 73(4):266-76. PubMed ID: 25731664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel gadolinium-based trimetasphere metallofullerene for application as a magnetic resonance imaging contrast agent.
    Adiseshaiah P; Dellinger A; MacFarland D; Stern S; Dobrovolskaia M; Ileva L; Patri AK; Bernardo M; Brooks DB; Zhou Z; McNeil S; Kepley C
    Invest Radiol; 2013 Nov; 48(11):745-54. PubMed ID: 23748228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Water-soluble polysaccharides as carriers of paramagnetic contrast agents for magnetic resonance imaging: synthesis and relaxation properties.
    Rongved P; Klaveness J
    Carbohydr Res; 1991 Jul; 214(2):315-23. PubMed ID: 1769023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extravascular toxicity of two magnetic resonance contrast agents. Preliminary experience in the rat.
    Cohan RH; Leder RA; Herzberg AJ; Hedlund LW; Wheeler CT; Beam CA; Nadel SN; Dunnick NR
    Invest Radiol; 1991 Mar; 26(3):224-6. PubMed ID: 2055727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
    Caravan P
    Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance of extracellular contrast agents for magnetic resonance imaging.
    Weinmann HJ; Press WR; Gries H
    Invest Radiol; 1990 Sep; 25 Suppl 1():S49-50. PubMed ID: 2283256
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclen-based Gd
    Rashid HU; Martines MAU; Jorge J; de Moraes PM; Umar MN; Khan K; Rehman HU
    Bioorg Med Chem; 2016 Nov; 24(22):5663-5684. PubMed ID: 27729196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution profile of gadolinium in gadolinium chelate-treated renally-impaired rats: role of pharmaceutical formulation.
    Fretellier N; Salhi M; Schroeder J; Siegmund H; Chevalier T; Bruneval P; Jestin-Mayer G; Delaloge F; Factor C; Mayer JF; Fabicki JM; Robic C; Bonnemain B; Idée JM; Corot C
    Eur J Pharm Sci; 2015 May; 72():46-56. PubMed ID: 25736527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble paramagnetic chelates and stabilized colloidal particle solutions of iron oxides as contrast agents for magnetic resonance imaging.
    Tombach B; Reimer P
    Curr Med Chem; 2005; 12(23):2795-804. PubMed ID: 16305473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Science to Practice: Will Gadolinium Chelates Be Replaced by Iron Chelates in MR Imaging?
    Tweedle MF
    Radiology; 2018 Feb; 286(2):409-411. PubMed ID: 29356647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Status of liposomes as MR contrast agents.
    Unger EC; Shen DK; Fritz TA
    J Magn Reson Imaging; 1993; 3(1):195-8. PubMed ID: 8428087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A comparative study between Gd-BOPTA, a biliary excretion contrast medium, and Gd-DTPA in the magnetic resonance imaging of the rat liver].
    Patrizio G; Pavone P; Cardone G; Pietroletti R; Passariello R; Tettamanti E; Musu C; Felder E
    Radiol Med; 1990 May; 79(5):458-62. PubMed ID: 2359853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basic principles of MR contrast.
    Nelson KL; Runge VM
    Top Magn Reson Imaging; 1995; 7(3):124-36. PubMed ID: 7654392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paramagnetic contrast agents in nuclear magnetic resonance medical imaging.
    Mendonça-Dias MH; Gaggelli E; Lauterbur PC
    Semin Nucl Med; 1983 Oct; 13(4):364-76. PubMed ID: 6359418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contrast media in hepatic MRI].
    Grellet J; Bellin MF; Dion E
    J Radiol; 1992 Oct; 73(10):495-9. PubMed ID: 1294722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular biodegradable macromolecular gadolinium(III) complexes for MRI.
    Lu ZR; Parker DL; Goodrich KC; Wang X; Dalle JG; Buswell HR
    Magn Reson Med; 2004 Jan; 51(1):27-34. PubMed ID: 14705042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.